Stage II and stage III colon cancer: treatment advances and future directions. - Wikidata - awgldk - TriplyDB

Stage II and stage III colon cancer: treatment advances and future directions.

Stage II and stage III colon cancer: treatment advances and future directions.

http://www.wikidata.org/entity/Q37762938

about

Integration of genome scale data for identifying new players in colorectal cancer Epigenetic Biomarkers in Colorectal Cancer.ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer.Lymph node retrieval in colorectal cancer: determining factors and prognostic significance High tumour cannabinoid CB1 receptor immunoreactivity negatively impacts disease-specific survival in stage II microsatellite stable colorectal cancer.Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence.Personalized colon cancer care in 2010.Ribosomal protein S27-like in colorectal cancer: a candidate for predicting prognoses.Prognostic significance of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer.The role of microRNAs in colorectal cancer.CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer.NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models.EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis.Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer Differential influence of inositol hexaphosphate on the expression of genes encoding TGF-β isoforms and their receptors in intestinal epithelial cells stimulated with proinflammatory agents.Usefulness of the preoperative administration of tegafur suppositories as alternative adjuvant chemotherapy for patients with resectable stage II or III colorectal cancer: a KODK4 multicenter randomized control trial.MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.Postoperative irinotecan in resected stage II-III rectal cancer: final analysis of the French R98 Intergroup trial†.

P2860

Q26774701-CC8BD959-97F4-4630-A6A7-0674C229F0FE Q30240778-D7AB8C4C-62A3-4AC7-B2E5-9EADB1D73687 Q33779292-E809C11E-89F9-4133-A2C5-A855A633B674 Q33841128-74AAA0EC-CDBC-4898-B9F4-63478F71C255 Q34013690-61978C40-74C6-43E8-A04E-80A74FC1BE79 Q34339927-B5B98F43-9843-4EAA-9EB4-54FAA30D550F Q34731381-4DC92AAF-D6B4-4906-A4C6-438EDAD9535B Q34796352-8170077B-5C00-4088-AADE-E3192FE176F0 Q35820715-FA786B28-B942-4FB2-AD9D-D0612466148C Q36096641-6A99222F-042D-4E10-B0CB-08A1BA8A5F92 Q36544662-66284410-6DF1-4E61-9A53-065F89BA0B40 Q36619390-2E3EF740-561E-4ED5-9FFD-19E8FE3A3E06 Q38019814-4E63993C-EC89-4A2E-B2FA-B4A076CDB7E0 Q38125964-987BB38B-A645-4F72-83E3-9F601EF349DC Q41871173-3D6A6FCF-624D-47A6-AA2C-4EE17FAB4E92 Q44042470-15CF7C9E-8827-4F3F-917F-F13B70D03E9F Q44542942-BC1588DD-0EE9-4160-9A90-605E2DB669B7 Q53589387-804DBEA7-5264-4183-95BC-A118F58F6CC4

P2860

Stage II and stage III colon cancer: treatment advances and future directions.

http://www.wikidata.org/entity/Q37762938

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Stage II and stage III colon cancer: treatment advances and future directions.

@en

Stage II and stage III colon cancer: treatment advances and future directions.

@nl

type

label

Stage II and stage III colon cancer: treatment advances and future directions.

@en

Stage II and stage III colon cancer: treatment advances and future directions.

@nl

prefLabel

Stage II and stage III colon cancer: treatment advances and future directions.

@en

Stage II and stage III colon cancer: treatment advances and future directions.

@nl

P1433

Q37762938-1F55832B-C8AD-4DF8-BFD9-D839CEC00028

P1476

Q37762938-5194CDBD-7CE4-4952-8794-BE7CE7C63E63

P2093

Q37762938-00E53A54-AFA0-4A32-BFB0-94300747CDDE

Q37762938-0ECC7A9A-A367-4B8E-A929-3860B65E4C78

Q37762938-16AAFA24-C130-4E57-A62C-3C18BC923FAA

Q37762938-2752C6DF-F3C7-4DDB-BC45-675F18CD16A4

Q37762938-6633E725-42BF-4E08-8718-D0F98637D1FF

Q37762938-6B0654B9-BF2F-4083-9859-8D48686E5EB9

Q37762938-742364DA-310C-4BB7-AA53-E7B9FC4A806E

Q37762938-95214AB0-3BAF-450A-BF94-81A544CB783B

P304

Q37762938-F59C51F9-45B6-416B-A26C-4A71DDB601F0

P31

Q37762938-DCBC49BF-CC4E-4EDE-B20F-95B4D88EDD50

P356

Q37762938-B7DE26DA-2BE6-4653-9A22-3BCB1834F103

P433

Q37762938-D6F3C0CE-967F-410E-ABB3-4F155A039C40

P478

Q37762938-4DB7AA33-82CB-4527-B0FB-F8BA42C10C8A

P50

Q37762938-BEF2EAAF-B12B-479F-897A-247352E03891

P577

Q37762938-FF14DBE2-C7B6-4DD9-BB75-129ECC4A63FD

P698

Q37762938-A5F4FD16-E48F-4CBF-BF73-79A91C2EBC75

P356

PPO.0B013E3181DDC5BF

P1433

The Cancer Journal

P1476

Stage II and stage III colon cancer: treatment advances and future directions.

@en

P2093

Annette K Larsen

http://www.w3.org/2001/XMLSchema#string

Benoist Chibaudel

http://www.w3.org/2001/XMLSchema#string

Benoît Rousseau

http://www.w3.org/2001/XMLSchema#string

Christophe Louvet

http://www.w3.org/2001/XMLSchema#string

Christophe Tournigand

http://www.w3.org/2001/XMLSchema#string

GERCOR (French Oncology Research Group)

http://www.w3.org/2001/XMLSchema#string

Jean-Baptiste Bachet

http://www.w3.org/2001/XMLSchema#string

Thierry André

http://www.w3.org/2001/XMLSchema#string

P304

202-209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PPO.0B013E3181DDC5BF

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Aimery de Gramont

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20526097

http://www.w3.org/2001/XMLSchema#string